PMID: 6107136Aug 1, 1980Paper

Propranolol in chronic schizophrenia: a controlled study in neuroleptic-treated patients

The British Journal of Psychiatry : the Journal of Mental Science
L H Lindström, E Persson

Abstract

The effect of propranolol at a dose level of 1,280-1,920 mg per day was studied with a double-blind crossover design in twelve chronic schizophrenics with persistent psychotic symptoms despite maintenance treatment with a depot neuroleptic. By use of a psychiatric rating scale (CPRS), an improvement was seen during the two week period of propranolol compared to placebo treatment in six patients, whereas three patients were unchanged and three deteriorated. The effect on total symptom scores for the whole group was significantly better after propranolol. The data indicate that propranolol in high doses has an antipsychotic effect in some schizophrenic patients when receiving neuroleptics.

References

Sep 17, 1977·Lancet·N J YorkstonH G Sergeant
May 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·G P Sheppard
Jan 24, 1970·Lancet·A Atsmon, I Blum
Aug 1, 1968·The Journal of Pharmacy and Pharmacology·R Laverty, K M Taylor
Jan 1, 1974·British Dental Journal·D H Goose
Dec 1, 1969·The British Journal of Psychiatry : the Journal of Mental Science·D Wheatley
Jun 11, 1978·The Journal of Applied Behavioral Science·D A Nadler

❮ Previous
Next ❯

Citations

Jan 1, 1984·Neuropharmacology·E MogilnickaA Delini-Stula
Jan 1, 1981·Neuroscience and Biobehavioral Reviews·L Kokkinidis, H Anisman
Jan 1, 1981·Pharmacology & Therapeutics·D N MiddlemissD T Greenwood
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·B B Sethi, S Dubé
Mar 1, 1991·Pharmacopsychiatry·D Naber, H Hippius
Nov 1, 1980·Lancet·T C Beard
Jan 1, 1991·Journal of Child and Adolescent Psychopharmacology·L E Arnold, M G Aman
Jan 13, 2004·Clinical Pharmacokinetics·Candace S BrownSamantha F Eichner
Sep 1, 1981·Journal of Clinical and Hospital Pharmacy·M Peet, R A Yates
Jan 1, 1981·Medicinal Research Reviews·L Patel, P Turner
Nov 1, 2001·The Cochrane Database of Systematic Reviews·M CheineK Wahlbeck
Jun 1, 1986·The British Journal of Psychiatry : the Journal of Mental Science·R Manchanda, S R Hirsch
Aug 1, 1981·The British Journal of Psychiatry : the Journal of Mental Science·M PeetR A Yates
Aug 1, 1981·The British Journal of Psychiatry : the Journal of Mental Science·M PeetR A Yates
Aug 1, 1981·The British Journal of Psychiatry : the Journal of Mental Science·D H MyersA Muir
Aug 1, 1983·The British Journal of Psychiatry : the Journal of Mental Science·C R PughR G Priest
Aug 1, 1986·The Laryngoscope·M HarellM Zohar
Dec 1, 1985·The British Journal of Psychiatry : the Journal of Mental Science·D EcclestonD A Stephens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The British Journal of Psychiatry : the Journal of Mental Science
J H GruzelierN J Yorkston
The British Journal of Psychiatry : the Journal of Mental Science
G P Sheppard
The British Journal of Psychiatry : the Journal of Mental Science
D J KingC D Kinney
© 2021 Meta ULC. All rights reserved